Market Capitalization Changement Date
Agios Pharmaceuticals USD 1.68B 434M 2024-03
ALKERMES USD 4.63B 36M 2023-12
Alterity Therapeutics Limited USD 11M 5M 2023-06
Amgen USD 148.35B 5.79B 2024-03
Baxter International USD 21.16B 1.55B 2024-03
BioCryst Pharmaceuticals USD 1.23B 115M 2023-12
Biogen USD 31.4B 6.09B 2024-03
Bluebird Bio USD 325M 25M 2023-09
Bristol-Myers Squibb USD 105.66B 1.26B 2024-03
Cara Therapeutics USD 91M 62M 2023-09
Cipla INR 1.01T 48.59B 2023-12
Dr.Reddys Laboratories INR 965.43B 35.54B 2023-12
Eisai JPY 2.09T 376.18B 2023-12
Eli Lilly USD 731.69B 178.32B 2024-03
Esperion Therapeutics USD 340M 235M 2023-12
Exelixis USD 7.26B 205M 2024-03
Gilead Sciences USD 90.93B 10.01B 2024-03
GlaxoSmithKline GBP 59.68B 1.42B 2023-12
Grifols USD 7.93B 102M 2023-09
Halozyme Therapeutics USD 5.12B 237M 2024-03
Incyte USD 12.89B 1.18B 2024-03
Ionis Pharmaceuticals USD 6.19B 1.07B 2024-03
Ironwood Pharmaceuticals USD 1.37B 416M 2024-03
Merck USD 314.33B 38.07B 2024-03
Nektar Therapeutics USD 113M 4M 2023-09
Neurocrine Biosciences USD 14.28B 1.33B 2024-03
Novartis CHF 193.29B 20.5B 2023-12
Pfizer USD 155.51B 7.05B 2024-03
Roche Holding CHF 199.67B 23.81B 2023-12
Sarepta Therapeutics USD 11.76B 2.73B 2024-03
Takeda JPY 6.42T 928.65B 2023-12
Teva Pharmaceutical Industries ILS 42.76B 315.46M 2023-12
Xencor USD 1.37B 81M 2024-03



Nektar Therapeutics Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.